InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Mark L. Jacobson
3 Sep 2026
Chief Operating Officer
Sold after exercise
10,000
$208.65
$2.09M
Herriot Tabuteau
6 Aug 2026
Chief Executive Officer
Sold after exercise
4,660
$213.95
$997.01K
Herriot Tabuteau
5 Aug 2026
Chief Executive Officer
Sold after exercise
45,004
$212.01
$9.54M
Herriot Tabuteau
1 Jul 2026
Chief Executive Officer
Sold after exercise
49,666
$240.25
$11.93M
Roger Jeffs
11 Jun 2026
Director
Sold on a plan
286
$249.12
$71.25K
Mark Coleman
10 Jun 2026
Director
Sold on a plan
643
$249.00
$160.11K
Susan Mahony
10 Jun 2026
Director
Sold on a plan
300
$246.18
$73.85K
Roger Jeffs
10 Jun 2026
Director
Sold on a plan
286
$246.18
$70.41K
Nick Pizzie
9 Jun 2026
Chief Financial Officer
Sold after exercise
33,000
$240.09
$7.92M
Herriot Tabuteau
9 Jun 2026
Chief Executive Officer
Sold after exercise
49,670
$241.01
$11.97M
Susan Mahony
9 Jun 2026
Director
Sold on a plan
300
$237.21
$71.16K
Mark Coleman
2 Jun 2026
Director
Sold on a plan
5,537
$223.39
$1.24M
Mark Coleman
1 Jun 2026
Director
Sold on a plan
6,000
$230.30
$1.38M
Mark Coleman
29 May 2026
Director
Sold on a plan
6,000
$233.46
$1.40M
Mark L. Jacobson
5 May 2026
Chief Operating Officer
Sold after exercise
233
$228.18
$53.17K
Mark L. Jacobson
4 May 2026
Chief Operating Officer
Sold after exercise
4,517
$227.94
$1.03M
Ari Maizel
22 Apr 2026
Chief Commercial Officer
Sold after exercise
7,500
$182.42
$1.37M
Mark L. Jacobson
26 Feb 2026
Chief Operating Officer
Sold after exercise
35,378
$161.88
$5.73M
Mark Coleman
26 Feb 2026
Director
Sold on a plan
25,000
$161.11
$4.03M
Mark Coleman
23 Feb 2026
Director
Exercised, kept
6,250
$4.95
$30.94K
Mark Coleman
20 Feb 2026
Director
Exercised, kept
12,485
$4.95
$61.80K
Mark Coleman
10 Feb 2026
Director
Exercised, kept
5,193
$8.02
$41.65K
Herriot Tabuteau
2 Feb 2026
Chief Executive Officer
Sold after exercise
32,410
$185.60
$6.02M
Nick Pizzie
22 Jan 2026
Chief Financial Officer
Sold after exercise
12,000
$187.92
$2.26M
Ari Maizel
21 Jan 2026
Chief Commercial Officer
Sold after exercise
7,500
$184.44
$1.38M
Herriot Tabuteau
7 Jan 2026
Chief Executive Officer
Sold after exercise
31,261
$170.38
$5.33M
Herriot Tabuteau
6 Jan 2026
Chief Executive Officer
Sold after exercise
29,450
$172.33
$5.08M
Herriot Tabuteau
5 Jan 2026
Chief Executive Officer
Sold after exercise
78,703
$171.28
$13.48M
Mark E Saad
31 Dec 2025
Director
Sold after exercise
31,346
$165.18
$5.18M
Mark E Saad
31 Dec 2025
Director
Sold after exercise
6,231
$165.18
$1.03M
Herriot Tabuteau
4 Dec 2025
Chief Executive Officer
Sold after exercise
10,558
$148.18
$1.56M
Herriot Tabuteau
3 Dec 2025
Chief Executive Officer
Sold after exercise
20,163
$146.94
$2.96M
Herriot Tabuteau
2 Dec 2025
Chief Executive Officer
Sold after exercise
49,252
$144.59
$7.12M

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 578,146
History held since 23 Nov 2015